Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions

Documenti analoghi

• Serum Levels of Prostate Specific Antigen, Free PSA, [‐2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions
  di: Yitong Weng, et al.
  Pubblicazione: (2025)
• Altered Glycosylation of PSA in Prostate Cancer Tissue
  di: Hannu Koistinen, et al.
  Pubblicazione: (2025)
• The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies
  di: Hikari Miura, et al.
  Pubblicazione: (2025)
• Refining the CHAARTED Classification: Clinical Utility of a Novel Integrated Risk Stratification Model Incorporating Gleason Grade and Biochemical Markers in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer
  di: Takanori Tokunaga, et al.
  Pubblicazione: (2025)
• Current Status of Prostate Biopsy in Africa: Are We Ready for a Targeted Biopsy?
  di: Ziba Ouima Justin Dieudonne, et al.
  Pubblicazione: (2025)